Select Page

ALIQOPA (copanlisib) for injection, for intravenous use. Initial U.S. Approval: 2017

ALIQOPA (copanlisib) for injection, for intravenous use. Initial U.S. Approval: 2017

ALIQOPA (copanlisib) for injection is an Anti Cancer medicine. ALIQOPA is used to treat follicular lymphoma.
INDICATIONS AND USAGE
ALIQOPA (copanlisib) for injection is a kinase inhibitor indicated for the treatment of adult patients with relapsed follicular lymphoma (FL) who have received at least two prior systemic therapies.
Accelerated approval was granted for this indication based on overall response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.
DOSAGE FORMS & STRENGTHS
For injection: 60 mg as a lyophilized solid in single-dose vial for reconstitution
Manufactured By: Bayer
Prescribing Information URL: Click Here

Procedure to buy ALIQOPA (copanlisib) for injection?
To buy ALIQOPA (copanlisib) for injection, patients can simply fill the order form or can send mail at info@bioniquehealthcare.com. or can also send Whatsapp message at +91 96677 50889. You will get reply within few hours with pricing and procedure details. Note:- the order will be confirmed only after the receipt of valid prescription of doctor.

Category:

Copanlisib (trade name Aliqopa /ˌælɪˈkoʊpə/ AL-ih-KOH-pah; codenamed BAY 80-6946) is a drug which is approved by US FDA for the treatment of adult patients experiencing relapsed follicular lymphoma who have received at least two prior systemic therapies

Copanlisib is an inhibitor of phosphatidylinositol-3-kinase (PI3K) with inhibitory activity predominantly against PI3K-α and PI3K-δ isoforms expressed in malignant B-cells. It has been shown to induce tumor cell death by apoptosis and inhibition of proliferation of primary malignant B cell lines.

Documentation

  1. Doctor’s Prescription – We would require prescription from registered medical practitioner stating product name, dosage, duration of treatment and diagnosis.
  2. Patient’s Medical history – We would require all test reports and medical reports of the patient for last 3 months.
  3. Patient’s Identity card – We will require scan copy of patient’s identity card and proof of residence to initiate documentation process. you can use copy of passport, driving license, employee ID card or any photo id document as your identity card.

For Indian Patient

Ani-Cancer ALIQOPA ™ (copanlisib) for injection are prescription drug. 

We facilitate by-

  • Helping in documentation to import the medicine for personal use.
  • Finding Genuine and reliable source in USA, Europe and Japan.
  • Ensuring 100% transparency.

ALIQOPA ™ (copanlisib) for injection can be shipped to Ahmedabad, Bangalore, Chennai, Cochin, Hyderabad, Delhi, Haryana, Jaipur, Jammu and Kashmir, Himachal Pradesh, Kolkata, Lucknow, Mumbai, Pune, Punjab and other cities in India. Bionique Healthcare does not manufacture, supply, re-sell or retail any drugs or medicines. 

For Overseas Patient

Can I get anti-cancer medicines even if I am not based in India?

Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country. The Bionique Healthcare can help patients in accessing/importing Ant-cancer medicines, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country.

Send your query to find the best price of –

ALIQOPA ™ (copanlisib) for injection in South East Asia – China (Beijing, Chongqing, Shanghai, Tianjin and Shenzhen), Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.
ALIQOPA ™ (copanlisib) for injection in United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.
ALIQOPA ™ (copanlisib) for injection in North America – Mexico.
ALIQOPA ™ (copanlisib) for injection in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.
ALIQOPA ™ (copanlisib) for injection in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.
ALIQOPA ™ (copanlisib) for injection in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.
ALIQOPA ™ (copanlisib) for injection in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.
ALIQOPA ™ (copanlisib) for injection in Australia and New Zealand.

Reviews

There are no reviews yet.

Be the first to review “ALIQOPA (copanlisib) for injection, for intravenous use. Initial U.S. Approval: 2017”

Your email address will not be published. Required fields are marked *

Anti-Cancer Medicine Supplier.

Bionique Healthcare is a consulting pharmaceutical company which assist Patients in accessing medicines in India. Bionique Healthcare facilitates such access only against valid prescriptions in conformity with all local laws and regulations.

Patients/ Clinicians / Researchers can contact Bionique at +91 9667750889 or write to at – info@bioniquehealthcare.com.

Product Disclaimer

Bionique Healthcare does not manufacture, supply, re-sell or retail any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by suppliers are owned by their respective manufacturer or licensee. 

Bionique Healthcare does not lay any claim on them.